You are here:
Challenges in Public Health Protection in the 21st Century: New Methods, Omics and Novel Concepts in Toxicology
(15.11.2021 - 17.11.2021)
The upcoming symposium aims to provide an update on major developments in the field of new emerging methods and concepts in toxicology. As a platform for researchers and representatives from academia, industry, and regulatory authorities, the symposium highlights methodological progress (e.g. in vitro, in silico, omics methods) as well as current and future applications for regulatory risk assessment. Its broader intention is to share and advance ideas on future possibilities and applications in the field.
The BfR-symposium on "New Methods, Omics and Novel Concepts in Toxicology – Current Application and future Directions" will be organised in frame of the larger BfR event dedicated to Challenges in Public Health Protection in the 21st Century, which also covers the 2nd International Conference on Tattoo Safety on 18 - 19 November 2021.
Link to the records of the presentations:
Programme
(1)| Date | Title | Size |
|---|---|---|
|
15.11.2021 Programme
|
Challenges in Public Health Protection in the 21st Century: New Methods, Omics and Novel Concepts in Toxicology |
465.2 KB
|
Presentation
(15)| Date | Title | Size |
|---|---|---|
|
17.11.2021 Presentation Dr Tomasz Sobanski, European Chemicals Agency (ECHA)
|
Experience of ECHA in applying NAMs in a regulatory context |
1.5 MB
|
|
17.11.2021 Presentation Dr Pascal Sanders, Occupational Health & Safety (ANSES)
|
Current applications - a regulatory authority perspective |
623.4 KB
|
|
17.11.2021 Presentation Dr Mirjam Luijten, National Institute for Public Health and the Environment (RIVM)
|
NAMs in chemical risk assessment: a new game requires new rules |
1.1 MB
|
|
17.11.2021 Presentation Professor Dr Vera Rogiers, Scientific Committee on Consumer Safety (SCCS)
|
New methods, OMICS and novel concepts in risk assessment of cosmetic ingredients |
1.2 MB
|
|
17.11.2021 Presentation Dr Toru Kawanishi, Food Safety Commission of Japan (FSCJ)
|
The perspective: Application of New Approach Methodologies to Food Risk Assessment by Food Safety Commission of Japan |
1.9 MB
|
|
17.11.2021 Presentation Dr Weida Tong, United States Food and Drug Administration (US FDA)
|
AI for Regulatory Science at FDA |
1.4 MB
|
|
16.11.2021 Presentation Professor Dr Martin von Bergen, UFZ
|
Integration of multi-(meta)omics in cellular and microbiome toxicity |
2.6 MB
|
|
16.11.2021 Presentation Professor Dr Roland Grafstroem, Karolinska Institute
|
Transcriptomics |
2.4 MB
|
|
16.11.2021 Presentation Professor Dr Bob van de Water, Leiden University
|
High throughput transcriptomics (HHTr) applications in read across: EU-ToxRisk experience |
5.7 MB
|
|
16.11.2021 Presentation Professor Dr Bennard van Ravenzwaay, BASF
|
Use of metabolomics for Read Across |
3.3 MB
|
|
16.11.2021 Presentation Dr Wibke Busch, UFZ
|
Toxicogenomics with the zebrafish embryo model - from individual observations to comprehensive mixture predictions |
1.9 MB
|
|
16.11.2021 Presentation Dr Oliver Poetz, Natural and Medical Science Institute (NMI), University of Tuebingen
|
Targeted Proteomics in Toxicology |
5.0 MB
|
|
15.11.2021 Presentation Professor Dr Thomas Hartung, Johns Hopkins Bloomberg School of Public Health (JHSPH)
|
Recent advances in the field |
5.3 MB
|
|
15.11.2021 Presentation Dr Anton Simeonov, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)
|
High-throughput screening to advance in vitro toxicology |
5.9 MB
|
|
15.11.2021 Presentation Dr Clemens Wittwehr, Joint Research Centre (JRC)
|
NAM-derived data in regulatory environments: Templates, AOPs and ontologies |
3.3 MB
|
- Follow us:
-
-
-
-
-
-
